Pennant Investors »

Replimune Group shares owned by Pennant Investors

Quarter-by-quarter ownership of Replimune Group (REPL) shares owned by Pennant Investors from 13F filings

Historical chart of Pennant Investors investment in Replimune Group

Tip: Access up to 7 years of quarterly data

All positions including Replimune Group held by Pennant Investors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Replimune Group by Pennant Investors

Quarter filed Position value Share count Share price at filing
2024-03-31 $249k 31k 8.17

More positions owned by Pennant Investors

Amazon (AMZN)
TransDigm Group Incorporated (TDG)
Antero Res Call Option (AR)
Microsoft Corporation (MSFT)
Micron Technology (MU)
Echostar Corp Cl A (SATS)
Alphabet Cap Stk Cl A (GOOGL)
Apple Put Option (AAPL)
Colfax Corp (ENOV)
ODP Corp. (ODP)
Perimeter Solutions Sa Common Stock (PRM)
Fibrogen (FGEN)
Arcutis Biotherapeutics (ARQT)
Altimmune Com New (ALT)
Fate Therapeutics (FATE)

View all positions for Pennant Investors

Top funds holding Replimune Group

Baker Bros. Advisors
T. Rowe Price Associates
State Street Corporation
Fcpm Iii Services B.v.
BlackRock
Redmile Group
Omega Fund Management
Vanguard Group
Camber Capital Management
Morgan Stanley
Atlas Venture Life Science Advisors
Geode Capital Management
Leucadia National Corporation
D. E. Shaw & Co
Dimensional Fund Advisors

View all funds holding Replimune Group